Johnson & Johnson (BKK:JNJ03)

Thailand flag Thailand · Delayed Price · Currency is THB
3.280
0.00 (0.00%)
At close: Dec 4, 2025
Market Cap 15.62T
Revenue (ttm) 2.97T
Net Income (ttm) 808.96B
Shares Out n/a
EPS (ttm) 333.25
PE Ratio 19.31
Forward PE 18.05
Dividend 0.02 (0.52%)
Ex-Dividend Date Nov 25, 2025
Volume 13,750
Average Volume 120,886
Open 3.280
Previous Close 3.280
Day's Range 3.280 - 3.300
52-Week Range 2.980 - 3.380
Beta n/a
RSI 58.85
Earnings Date Jan 21, 2026

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo... [Read more]

Industry Pharmaceutical Preparations
Founded 1886
Employees 138,100
Stock Exchange Stock Exchange of Thailand
Ticker Symbol JNJ03
Full Company Profile

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD Financial Statements

News

There is no news available yet.